233 related articles for article (PubMed ID: 16137431)
1. Sentinel lymph node biopsy in the management of ductal carcinoma in situ.
Zujewski J; Eng-Wong J
Clin Breast Cancer; 2005 Aug; 6(3):216-22. PubMed ID: 16137431
[TBL] [Abstract][Full Text] [Related]
2. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
3. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
[TBL] [Abstract][Full Text] [Related]
4. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.
Maffuz A; Barroso-Bravo S; Nájera I; Zarco G; Alvarado-Cabrero I; Rodríguez-Cuevas SA
J Exp Clin Cancer Res; 2006 Jun; 25(2):223-7. PubMed ID: 16918134
[TBL] [Abstract][Full Text] [Related]
5. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
6. The role of sentinel lymph node biopsy in ductal carcinoma in situ.
Moran CJ; Kell MR; Kerin MJ
Eur J Surg Oncol; 2005 Dec; 31(10):1105-11. PubMed ID: 16084681
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy for localised ductal carcinoma in situ?
Veronesi P; Intra M; Vento AR; Naninato P; Caldarella P; Paganelli G; Viale G
Breast; 2005 Dec; 14(6):520-2. PubMed ID: 16185871
[TBL] [Abstract][Full Text] [Related]
8. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
Han JS; Molberg KH; Sarode V
Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
[TBL] [Abstract][Full Text] [Related]
9. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
[TBL] [Abstract][Full Text] [Related]
10. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up.
Lara JF; Young SM; Velilla RE; Santoro EJ; Templeton SF
Cancer; 2003 Nov; 98(10):2105-13. PubMed ID: 14601079
[TBL] [Abstract][Full Text] [Related]
11. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
Wilkie C; White L; Dupont E; Cantor A; Cox CE
Am J Surg; 2005 Oct; 190(4):563-6. PubMed ID: 16164920
[TBL] [Abstract][Full Text] [Related]
12. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.
Tan JC; McCready DR; Easson AM; Leong WL
Ann Surg Oncol; 2007 Feb; 14(2):638-45. PubMed ID: 17103256
[TBL] [Abstract][Full Text] [Related]
13. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
14. The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ.
Hung WK; Ying M; Chan M; Mak KL; Chan LK
Breast Cancer; 2010 Oct; 17(4):276-80. PubMed ID: 19756924
[TBL] [Abstract][Full Text] [Related]
15. Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.
Meretoja TJ; Heikkilä PS; Salmenkivi K; Leidenius MH
Ann Surg Oncol; 2012 Jul; 19(7):2345-51. PubMed ID: 22395995
[TBL] [Abstract][Full Text] [Related]
16. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data.
Porembka MR; Abraham RL; Sefko JA; Deshpande AD; Jeffe DB; Margenthaler JA
Ann Surg Oncol; 2008 Oct; 15(10):2709-19. PubMed ID: 18483831
[TBL] [Abstract][Full Text] [Related]
18. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ.
Dominguez FJ; Golshan M; Black DM; Hughes KS; Gadd MA; Christian R; Lesnikoski BA; Specht M; Michaelson J; Smith BL
Ann Surg Oncol; 2008 Jan; 15(1):268-73. PubMed ID: 17891441
[TBL] [Abstract][Full Text] [Related]
19. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P
Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
[TBL] [Abstract][Full Text] [Related]
20. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
